Incorporating end-user perspectives into the development of a machine learning algorithm for first time perinatal depression prediction

将最终用户视角融入到用于首次预测围产期抑郁症的机器学习算法的开发中

阅读:1

Abstract

OBJECTIVE: Machine learning algorithms can advance clinical care, including identifying mental health conditions. These algorithms are often developed without considering the perspectives of the affected populations. This study describes the process of incorporating end-user perspectives into the development and implementation planning of a prediction algorithm for new perinatal depression onset. MATERIALS AND METHODS: A focus group (N = 12 providers) and four virtual community engagement studios (N = 21 patients) were conducted. The project team presented on the initial development of a novel prediction algorithm used to detect first time perinatal depression. Rapid qualitative analysis coded the prediction algorithm's completeness, interpretability, and acceptability to stakeholders, with the goal of informing clinical implementation of a patient-facing screener produced from the prediction algorithm. RESULTS: Providers and patients showed consensus on the interpretability of the prediction algorithm's variables and discussed additional variables believed to be predictive of depression to ensure its completeness. In terms of acceptability, patients expressed a desire to discuss predictive risk screening results with their provider, while providers voiced concerns about limited bandwidth for these discussions. Both groups identified the need for post-screening resource connection but raised concerns over the availability of depression prevention specific resources. Providers and patients reported positively about their engagement in the sessions. DISCUSSION: Qualitative findings were incorporated into iterative algorithm development and informed an implementation pilot plan. CONCLUSION: This study demonstrates how the expertise of the end-users of a risk prediction algorithm can be incorporated into its development, which may ultimately increase clinical adoption.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。